Botanix Pharmaceuticals Limited (BOT.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:10PM AEDT
| Previous close | 0.3700 |
| Open | 0.3700 |
| Bid | 0.3700 x 0 |
| Ask | 0.3750 x 0 |
| Day's range | 0.3650 - 0.3800 |
| 52-week range | 0.1200 - 0.4450 |
| Volume | |
| Avg. volume | 6,781,191 |
| Market cap | 689.336M |
| Beta (5Y monthly) | 1.71 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings date | 30 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 0.55 |
Simply Wall St.Breakeven Is Near for Botanix Pharmaceuticals Limited (ASX:BOT)
We feel now is a pretty good time to analyse Botanix Pharmaceuticals Limited's ( ASX:BOT ) business as it appears the...
Simply Wall St.Botanix Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Botanix Pharmaceuticals ( ASX:BOT ) Full Year 2024 Results Key Financial Results Net loss: AU$13.9m (loss widened by...
Simply Wall St.Unveiling Three ASX Growth Companies With High Insider Ownership
The Australian stock market is currently experiencing a downturn, with the ASX200 down by 0.45% and most sectors showing declines. Notably, IT and healthcare sectors have faced significant losses, while real estate has shown some resilience amidst recent economic turbulence highlighted by a surprising inflation report. In such a market context, companies with high insider ownership can be particularly compelling as they often indicate that those closest to the business are confident in its...
© 2024 Yahoo. All rights reserved.